发明名称 OXAZOLIDONE DERIVATIVE
摘要 An oxazolidone derivative represented by the following general formula (I) or a pharmacologically acceptable salt thereof which has a monoamine oxidase inhibition effect: <IMG> (I) {wherein A and B each represents a nitrogen atom, a sulfur atom or an oxygen atom, with the proviso that at least one of A and B must be a nitrogen atom, R1 represents a group such as a group represented by the formula: <IMG> (in which n and m each represents 0 or an integer of 1 to 4, and R3 and R4 each represents a hydrogen atom, a hydroxyl group, a lower alkyl group, etc.), a group represented by the formula: <IMG> (in which p and q each represents 0 or an integer of 1 to 4 and X represents an oxygen atom, sulfur atom, etc.) and a group represented by the formula: <IMG> (in which R5 and R6 each represents a hydrogen atom or a group such as a cyanoalkyl group, or R5 and R6 may form a ring together with the nitrogen atom to which they are bonded), R2 represents a hydrogen atom or a lower alkyl group, and the bond represented by <IMG> represents a single or double bond}.
申请公布号 CA2116337(A1) 申请公布日期 1993.04.29
申请号 CA19922116337 申请日期 1992.09.30
申请人 EISAI CO LTD 发明人 AKASAKA KOZO;KAJIWARA AKIHARU;NAGATO SATOSHI;IIMURA YOUICHI;YOSHIDA ICHIROU;SASAKI ATSUSHI;MIZUNO MASANORI;KUBOTA ATSUHIKO;KAGAYA TAKAKI;KOMATSU MARIKO
分类号 A61K31/42;A61K31/423;A61K31/425;A61K31/445;A61P25/24;A61P25/26;C07D263/56;C07D263/57;C07D263/58;C07D417/04;C07D417/14;(IPC1-7):C07D417/04;C07D413/04;A61K31/41;A61K31/535 主分类号 A61K31/42
代理机构 代理人
主权项
地址